Edition:
United Kingdom

Profile: Eris Lifesciences Ltd (ERIS.NS)

ERIS.NS on National Stock Exchange of India

499.40INR
14 Jun 2019
Change (% chg)

Rs-10.60 (-2.08%)
Prev Close
Rs510.00
Open
Rs500.50
Day's High
Rs520.00
Day's Low
Rs495.10
Volume
8,353
Avg. Vol
19,523
52-wk High
Rs786.00
52-wk Low
Rs486.65

Eris Lifesciences Limited is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market. The Company operates within various areas through its seven focused divisions: Eris, Nikkos, Adura, Montana, Inspira, Victus, Eris Kinedex, Eterna, and Altiza. Its Eris division includes Atorsave 10, Atorsave 20, Decal, Enoxsave 0.6 and Metaloc XL100 products; its Nikkos division includes Alerfix, Erinac D, Ezeepam Plus 5, Zenpride OD and Nikotriol products; its Adura division includes Crevast 5, Glitaris M30, Metafort G1 CP and Olmin 10 products; its Montana division includes Meftaris, Calshine 60K Sachet, Hinder, Rabemon 20 and Vomisave Syrup products; its Inspira division includes Crevast F 5, Lnbeta 5 and Twichek products, and its Victus division includes Atorsave D80, Cyblex M 30 XR, Cyblex M 80, Cyblex M 60 XR and Cyblex MV 40.3 products.

Company Address

Eris Lifesciences Ltd

7th Floor, Commerce House IV,,
Beside Shell Petrol Pump, 100 Fe
AHMEDABAD     380015
P: +9179.30451111
F: +9179.30179404

Company Web Links